Skip to main content

Table 1 Patient characteristics

From: 11C-acetate PET/CT in pre-therapeutic lymph node staging in high-risk prostate cancer patients and its influence on disease management - a retrospective study

  n Mean Range
Patients (n) 50   
Age (years)   67 41 to 77
PSA (ng/ml)   37 2.7 to 168
Gleason score   8 6 to 10
Estimated risk of locoregional lymph node metastases (%)a   32 3.3 to 80.3
  1. aAccording to the Cagiannos pre-treatment nomogram, where age, pre-treatment PSA, clinical tumour stage, primary and secondary Gleason grade, and the number of positive and negative biopsy cores influence the estimated risk.